Internal: Archive

Virtual humans show way forward for tourism

This content was published on Sep 21, 2004 The Federal Institute of Technology programme shows planners what is likely to attract or deter tourists. It is based on information collected in the mountain village of Schönried near Gstaad. The winter ski resort has recently suffered a dearth of snow, due to its relatively low altitude of 1,200 metres. As climate change continues to…

Swiss lead Europe in telecoms service quality

This content was published on Sep 21, 2004 It also tops the list in terms of the overall price-quality trade-off. These are two of the key findings of a report published jointly on Tuesday by Zurich University’s socioeconomic institute and specialist consultancy Plaut Economics. However, some of the report’s findings have been criticised by key players in the Swiss telecoms sector – in…

Industry enjoys growth surge

This content was published on Sep 21, 2004 The figures, released by the Federal Statistical Office, showed that industrial production had also jumped by 4.3 per cent, providing more evidence of an economic recovery. Production rose 2.6 per cent in the first quarter compared with the same period last year, confirming a growth trend. Orders in the second quarter were also up over…

Exports continue to drive economic recovery

This content was published on Sep 21, 2004 All sectors benefited from the growth, but exports to China and Russia and watch exports to the United States were particularly strong. “In terms of exports, sector-wise the metal and watch industry, the chemical industry as well as the food and consumer goods industry shone with gains of over ten per cent,” the Customs Office…

Syngenta wins key patent protection case in China

This content was published on Sep 20, 2004 The ruling is seen in some circles as a sign that the Chinese authorities are making more efforts to protect intellectual property rights. Syngenta is one of a number of foreign investors in China taking more aggressive legal steps to crack down on what they see as blatant copyright and patent infringements. “Syngenta is on…

Health costs continue to spiral

This content was published on Sep 20, 2004 The forecast comes one week before the annual hike in premiums is due to be officially announced, and is in line with basic health costs which have risen 24 per cent in the past five years. The announcement on Monday by Santésuisse, the umbrella organisation of health insurance companies, coincides with the release of a…

Vote seeks to thwart Post Office’s cost cutting

This content was published on Sep 20, 2004 They argue postal services are crucial for the public, particularly in rural areas. But opponents say the state-owned Post Office has to make cuts to stay competitive. Voters will decide on September 16 whether to support the people’s initiative, launched by a trade union and the country’s main consumer organisation. Its backers want to ensure…

Roche announces positive test for key cancer drug

This content was published on Sep 20, 2004 Pancreatic cancer, for which current treatment options are limited, was the focus of the latest trial. William Burns, head of Roche’s pharmaceuticals division, said: “The survival benefit delivered in this study is particularly exciting, as these results come on top of good data for lung cancer. “This means new hope for pancreatic patients who currently…

Banking chief highlights costs of regulation

This content was published on Sep 17, 2004 Urs Roth told swissinfo that regulatory requirements now account for up to ten per cent of the work in Swiss banks – with smaller institutions particularly hard hit. Roth was speaking after the SBA’s annual media conference on Thursday, which also saw the publication of a first-ever survey of the short-term prospects for the sector.…

Tailored drugs risk leaving the poor untreated

This content was published on Sep 17, 2004 Pharmacogenetic tests, pioneered by the Swiss drug firm Roche, promise more effective and safer treatments, but the implications are not all therapeutic. Despite incredible progress made in recent decades, medicine remains anything but an exact science. New drugs coming onto the market generally have a success rate of between 70 and 80 per cent. “Try…

Internal: Archive

Popular Stories

Most Discussed

Internal: Archive

More

Virtual humans show way forward for tourism

More

Swiss lead Europe in telecoms service quality

More

Industry enjoys growth surge

More

Exports continue to drive economic recovery

More

Syngenta wins key patent protection case in China

More

Health costs continue to spiral

More

Vote seeks to thwart Post Office’s cost cutting

More

Roche announces positive test for key cancer drug

More

Banking chief highlights costs of regulation

More

Tailored drugs risk leaving the poor untreated

Popular Stories

Most Discussed